Exactech Q2 Revenue Up 8% to $66.1 Million. Net Income up 20% to $4.4 Million. Diluted EPS $0.31 vs. $0.26.
Gainesville, Fla. (Aug. 1, 2016) – Exactech (Nasdaq: EXAC), a developer and producer of bone and joint restoration products for hip, knee, shoulder, spine and biologic materials, today announced revenue…